232 related articles for article (PubMed ID: 34157324)
1. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
[TBL] [Abstract][Full Text] [Related]
2. The clinical pattern of nephrotic syndrome in children has no effect on the concentration of soluble urokinase receptor (suPAR) in serum and urine.
Ochocińska A; Jarmużek W; Janas R
Pol Merkur Lekarski; 2018 Apr; 44(262):183-187. PubMed ID: 29775445
[TBL] [Abstract][Full Text] [Related]
3. Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children.
Peng Z; Mao J; Chen X; Cai F; Gu W; Fu H; Shen H; Wang J; Jin X; Zhu X; Liu A; Shu Q; Du L
Pediatr Nephrol; 2015 Feb; 30(2):301-7. PubMed ID: 25034499
[TBL] [Abstract][Full Text] [Related]
4. Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes.
Alfano M; Cinque P; Giusti G; Proietti S; Nebuloni M; Danese S; D'Alessio S; Genua M; Portale F; Lo Porto M; Singhal PC; Rastaldi MP; Saleem MA; Mavilio D; Mikulak J
Sci Rep; 2015 Sep; 5():13647. PubMed ID: 26380915
[TBL] [Abstract][Full Text] [Related]
5. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
[TBL] [Abstract][Full Text] [Related]
6. [Role of podocyte injury signaling pathway in steroid-resistant nephrotic syndrome and research progress in traditional Chinese medicine intervention].
Yu WX; Yan W; Dai EL; Tian WX; Dang WJ
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3246-3254. PubMed ID: 37382008
[TBL] [Abstract][Full Text] [Related]
7. Glomerular Transcriptome Profiles in Focal Glomerulosclerosis: New Genes and Pathways for Steroid Resistance.
Tong J; Jin Y; Weng Q; Yu S; Jafar Hussain HM; Ren H; Xu J; Zhang W; Li X; Wang W; Xie J; Chen N
Am J Nephrol; 2020; 51(6):442-452. PubMed ID: 32348995
[TBL] [Abstract][Full Text] [Related]
8. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid receptors and their upstream epigenetic regulators in adults with steroid-resistant nephrotic syndrome.
Rahbar Saadat Y; Hejazian SM; Nariman-Saleh-Fam Z; Bastami M; Poursheikhani A; M Shoja M; Ardalan M; Zununi Vahed S
Biofactors; 2020 Nov; 46(6):995-1005. PubMed ID: 33031585
[TBL] [Abstract][Full Text] [Related]
10. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
11. Further Evidence That the Soluble Urokinase Plasminogen Activator Receptor Does Not Directly Injure Mice or Human Podocytes.
Harel E; Shoji J; Abraham V; Miller L; Laszik ZG; King A; Dobi D; Szabo G; Hann B; Sarwal MM; Craik CS; Vincenti F
Transplantation; 2020 Jan; 104(1):54-60. PubMed ID: 31449183
[TBL] [Abstract][Full Text] [Related]
12. Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes.
Nusshag C; Stütz A; Hägele S; Speer C; Kälble F; Eckert C; Brenner T; Weigand MA; Morath C; Reiser J; Zeier M; Krautkrämer E
Sci Rep; 2020 Nov; 10(1):19117. PubMed ID: 33154421
[TBL] [Abstract][Full Text] [Related]
13. The impact of steroids on the injured podocytes in nephrotic syndrome.
Hosseiniyan Khatibi SM; Ardalan M; Abediazar S; Zununi Vahed S
J Steroid Biochem Mol Biol; 2020 Feb; 196():105490. PubMed ID: 31586640
[TBL] [Abstract][Full Text] [Related]
14. Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.
Jiang L; Dasgupta I; Hurcombe JA; Colyer HF; Mathieson PW; Welsh GI
Clin Sci (Lond); 2015 Jun; 128(12):883-93. PubMed ID: 25626449
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic and antiproteinuric effects of salvianolic acid A in combined with low-dose prednisone in minimal change disease rats: Involvement of PPARγ/Angptl4 and Nrf2/HO-1 pathways.
Wang X; Qi D; Fu F; Li X; Liu Y; Ji K; Gao Z; Kong L; Yu C; Xie H; Yue G; Zhu H; Liu K; Fan H
Eur J Pharmacol; 2019 Sep; 858():172342. PubMed ID: 31129156
[TBL] [Abstract][Full Text] [Related]
16. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
[TBL] [Abstract][Full Text] [Related]
17. Mutations in KIRREL1, a slit diaphragm component, cause steroid-resistant nephrotic syndrome.
Solanki AK; Widmeier E; Arif E; Sharma S; Daga A; Srivastava P; Kwon SH; Hugo H; Nakayama M; Mann N; Majmundar AJ; Tan W; Gee HY; Sadowski CE; Rinat C; Becker-Cohen R; Bergmann C; Rosen S; Somers M; Shril S; Huber TB; Mane S; Hildebrandt F; Nihalani D
Kidney Int; 2019 Oct; 96(4):883-889. PubMed ID: 31472902
[TBL] [Abstract][Full Text] [Related]
18. 1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria.
Ma J; Zhang B; Liu S; Xie S; Yang Y; Ma J; Deng Y; Wang W; Xu L; Li R; Zhang L; Yu C; Shi W
PLoS One; 2013; 8(5):e64912. PubMed ID: 23741418
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of cultured podocytes exposed to nephrotic plasma reveals intrinsic molecular signatures of nephrotic syndrome.
Panigrahi S; Pardeshi VC; Chandrasekaran K; Neelakandan K; Ps H; Vasudevan A
Clin Exp Pediatr; 2021 Jul; 64(7):355-363. PubMed ID: 33147911
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome.
Aviles DH; Matti Vehaskari V; Manning J; Ochoa AC; Zea AH
Kidney Int; 2004 Jul; 66(1):60-7. PubMed ID: 15200413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
